title: Acute progression of severe insulin edema accompanied by pericardial and pleural effusion in a patient with type 2 diabetes.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kawashima
authors.forename: Hideaki
authors.initials: H
authors.lastname: Kaneto
authors.forename: Ken'ya
authors.initials: K
authors.lastname: Sakamoto
authors.forename: Tetsuyuki
authors.initials: T
authors.lastname: Yasuda
authors.forename: Akio
authors.initials: A
authors.lastname: Kuroda
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Shiraiwa
authors.forename: Kaoru
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Kasami
authors.forename: Taka-aki
authors.initials: TA
authors.lastname: Matsuoka
authors.forename: Yoshimitsu
authors.initials: Y
authors.lastname: Yamasaki
authors.forename: Munehide
authors.initials: M
authors.lastname: Matsuhisa
mesh_terms: D000284:Administration, Oral; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D018450:Disease Progression; D004487:Edema / Q000139:chemically induced* / Q000503:physiopathology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007294:Inositol / Q000031:analogs & derivatives / Q000627:therapeutic use; D007336:Insulin, Isophane / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010490:Pericardial Effusion / Q000139:chemically induced / Q000503:physiopathology*; D010996:Pleural Effusion / Q000139:chemically induced / Q000503:physiopathology; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
chemical_list: D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D007294:Inositol; D007336:Insulin, Isophane; C057619:glimepiride; C102817:voglibose